InsidersTradesSigma
Milestone Pharmaceuticals Inc.: management transactions · United States · SEC (Form 4)
SEC:milestone-pharmaceuticals-inc-45df15US·SEC (Form 4)Mcap 179M€Healthcare
Browse the full directors' dealings record of Milestone Pharmaceuticals Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Milestone Pharmaceuticals Inc. has recorded 1 insider filings. Market capitalisation: €178.9m. The latest transaction was disclosed on 1 June 2022 (Levée d'options). Among the most active insiders: TRUEX PAUL F. Every trade is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.50 €
Analyst consensus
6 analystsStrong buy
2.00 €Target 6.33 €(+324%)8.00 €
Income statement
Revenue1.5 M€
Net income−63.1 M€-4078.8% margin
Valuation
PER (forward)-1.4x
P/Book4.4x
Beta1.04
Balance sheet & cash
Market cap178.9 M€
Total debt58.4 M€
Free Cash Flow−49.3 M€
Debt / Equity140%
Profitability & ownership
ROE-229.7%
ROA-41.1%
% insiders2.5%
% institutions25.0%
Last declaration on 1 June 2022
Declarations0 total
No declarations found
0 of 0 declarations